Off-Pump Coronary Artery Bypass Grafting with Malignant Tumor Resection Involving Different Organs: The Comparison of Long-Term Prognosis and Risk Factor Analysis Related to Survival

Authors

  • Yiding Zhang, MD Department of Cardiac Surgery, Peking University First Hospital, Beijing, China https://orcid.org/0000-0002-8740-8695
  • Fei Li, MD Department of Cardiac Surgery, Peking University First Hospital, Beijing, China
  • Yang Yang, MD Department of Cardiac Surgery, Peking University First Hospital, Beijing, China
  • Feng Xiao, MD Department of Cardiac Surgery, Peking University First Hospital, Beijing, China
  • Jin Wang, MD Department of Cardiac Surgery, Peking University First Hospital, Beijing, China

DOI:

https://doi.org/10.1532/hsf.4857

Keywords:

coronary artery disease, off-pump coronary revascularization, tumor operation, simultaneous surgery, long-term survival

Abstract

Background: This study aimed to analyze the influence of the primary site of tumor location on off-pump coronary artery bypass grafting (OPCABG) surgery combined with concurrent tumor resection and to identify factors affecting long-term survival.

Methods: Fifty-seven patients with coronary artery disease (CAD) and malignancy who underwent simultaneous surgery retrospectively were enrolled. The primary site of tumor locations and cancer stage were used as a basis for grouping. The long-term survival among the subgroups was compared, and the risk factors related to survival were analyzed.

Results: The median follow-up period was 40 months. The 5-year cumulative survival rate of patients undergoing OPCABG and tumor resection was 74%. There was no significant difference in long-term survival among the four oncological location subgroups (P = 0.8), while significant difference was found among the two cancer stage subgroups (P = 0.0076). On univariable and multivariable Cox regression analysis, only cancer stage was an independent predictor of the long-term mortality rate (hazard ratio 5.42, P = 0.007).

Conclusion: For patients with potentially curable cancer and surgically correctable CAD, the safety of simultaneous surgery is confident. The primary site of tumor location does not significantly affect the long-term survival of these patients. The long-term survival rate strongly correlates with tumor stage.

References

Bablekos GD, Analitis A, Michaelides SA, et al. 2016. Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis. Ann Transl Med. 4: 213.

Chen L, Zhu XJ, Zhu RY, et al. 2021. Cardiopulmonary bypass does not consequentially contribute to postoperative distant metastasis of giant refractory thoracic tumors: A retrospective study with long-term follow-up. Thorac Cancer. 12: 2990-5.

Cheng SZ, Jiang YY, Li X, et al. 2021. Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis. J Cardiothorac Surg. 16: 227.

Collaborators GBDCoD. 2018. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392: 1736-88.

Darwazah AK. 2012. Surgical management of coronary artery disease associated with malignancy. J Card Surg. 27: 581-8.

Darwazah AK, Shehata S. 2011. Detrimental effect of cardiopulmonary bypass (CPB) on malignant disease. J Cardiothorac Surg. 6: 13.

Dedeilias P, Nenekidis I, Koletsis E, et al. 2010. Simultaneously performed off-pump coronary artery bypass grafting and colectomy: a case report. World J Surg Oncol. 8: 50.

Ding CZ, Wang GL, Wang HT, et al. 2021. Esophagectomy combined with off-pump coronary artery bypass grafting through left posterolateral incision is safe and feasible for esophageal cancer associated with coronary artery disease. Dis Esophagus. 34:doaa123.

Dong SY, Wang J, Xiao F. 2021. Perioperative safety of simultaneous off-pump coronary artery bypass grafting with non-cardiac surgery of moderate-to-severe severity. Coron Artery Dis. 32(5): 411-7.

Dong SY, Wang J, Zhang SY et al. 2021. [Perioperative safety and feasibility of simultaneous off-pump coronary artery bypass grafting with non-cardiac surgical procedures of moderate-to-severe severity]. Zhonghua Wai Ke Za Zhi. 59: 46-51.

Fan GH, Zhang LF. 2015. [Sudden cardiac death:progress in epidemiological research]. Zhonghua Liu Xing Bing Xue Za Zhi. 36: 87-9.

Garatti A, D'Ovidio M, Saitto G, et al. 2020. Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results. Eur J Cardiothorac Surg. 58: 528-36.

Guha A, Dey AK, Kalra A, et al. 2020. Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States. Mayo Clin Proc. 95: 1865-76.

Hirose H, Amano A, Yoshida S, et al. 2000. Coronary artery bypass grafting in patient with malignant neoplasm. Efficacy of coronary artery bypass grafting on beating heart. Jpn J Thorac Cardiovasc Surg. 48: 96-100.

Knudsen F, Andersen LW. 1990. Immunological aspects of cardiopulmonary bypass. J Cardiothorac Anesth. 4: 245-58.

Liu B, Gu C, Wang YL, et al. 2017. Feasibility and efficacy of simultaneous off-pump coronary artery bypass grafting and esophagectomy in elderly patients. Oncotarget. 8: 46498-505.

Nguyen HG, Tilki D, Dall'Era MA, et al. 2015. Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. J Urol. 194: 304-8.

Potts JE, Iliescu CA, Lopez Mattei JC, et al. 2019. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. Eur Heart J. 40: 1790-800.

Suzuki M, Tomoike H, Sumiyoshi T, et al. 2017. Incidence of cancers in patients with atherosclerotic cardiovascular diseases. Int J Cardiol Heart Vasc. 17: 11-6.

Takahashi T, Nakano S, Shimazaki Y, et al. 1995. Concomitant coronary bypass grafting and curative surgery for cancer. Surg Today. 25: 131-5.

To AC, Frost C, Grey AB et al. 2007. Combined coronary artery bypass grafting and phaeochromocytoma excision. Anaesthesia 62: 728-33.

Tourmousoglou CE, Apostolakis E, Dougenis D. 2014. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy? Interact Cardiovasc Thorac Surg. 19: 673-81.

Wang Z, Guo F, Li JZ, et al. 2021. Safety and efficacy of lobectomy combined with off-pump coronary artery bypass grafting for lung cancer. J Thorac Dis. 13: 4438-47.

Yang Y, Xiao F, Wang J, et al. 2016. Simultaneous surgery in patients with both cardiac and noncardiac diseases. Patient Prefer Adherence. 10: 1251-8.

Yang Y, Xiao F, Wang J, et al. 2021. [One-stage surgery in patients with both cardiac and non-cardiac diseases]. Beijing Da Xue Xue Bao Yi Xue Ban. 53: 327-31.

Zhao J, Han Y, Lei J, et al. 2017. Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival. Dis Esophagus. 30: 1-5.

Published

2022-08-31

How to Cite

Zhang, Y., Li, F., Yang, Y., Xiao, F., & Wang, J. (2022). Off-Pump Coronary Artery Bypass Grafting with Malignant Tumor Resection Involving Different Organs: The Comparison of Long-Term Prognosis and Risk Factor Analysis Related to Survival. The Heart Surgery Forum, 25(4), E621-E629. https://doi.org/10.1532/hsf.4857

Issue

Section

Article